ETC

Recommend
Index
  • Adacel

    Adacel

    Ingredient

    noninfectious tetanus, diphtheria, and pertussis proteins, aluminum
    phosphate, 2-phenoxyethanol, and residual amounts of formaldehyde and glutaraldehyde.

    Content
    Indication

    active booster immunization against
    tetanus, diphtheria and pertussis. Adacel is approved for use in persons 10
    through 64 years of age.

  • Aggrastat Inj.

    Aggrastat Inj.

    Ingredient

    Tirofiban Hydrochloride Hydrate 

    Content

    14.05mg/50ml (12.5mg/50ml as tirofiban)

    Indication

    Co-administration with heparin in the patients who are:
    – target patients in the treatment of acute coronary syndrome (ACS)
    – patients with percutaneous transluminal coronary angioplasty (PTCA) or atherectomy

    It has been shown to reduce the incidence of death, myocardial infarction, or combined endpoints of refractory ischemia/recardiac procedures.

  • Allegra Tab. 180mg

    Allegra Tab. 180mg

    Ingredient

    Fexofenadine Hydrochloride

    Content

    180mg

    Indication

    Relief of symptoms associated with allergic skin disease (chronic idiopathic urticaria).

  • Allegra Tab. 30mg

    Allegra Tab. 30mg

    Ingredient

    Fexofenadine Hydrochloride

    Content

    30mg

    Indication

    Relief of symptoms associated with seasonal allergic rhinitis and allergic skin diseases (chronic idiopathic urticaria)

  • Amaryl M Tab.

    Amaryl M Tab.

    Ingredient

    Glimepiride/Metformin Hydrochloride

    Content

    1/250mg, 1/500mg, 2/500mg

    Indication

    This drug is administered as an adjunct to diet and exercise to improve the glucose control of patients with type 2 diabetes who are adequate to combination therapy of glimepiride and metformin.

  • Amaryl Mex SR Tab.

    Amaryl Mex SR Tab.

    Ingredient

    Glimepiride/Metformin Hydrochloride

    Content

    2mg/500mg

    Indication

    This drug is administered as an adjunct to diet and exercise to improve the glucose control of patients with type 2 diabetes who are adequate to combination therapy of glimepiride and metformin.

  • Amaryl Tab.

    Amaryl Tab.

    Ingredient

    Glimepiride

    Content

    1mg, 2mg, 4mg

    Indication

    This drug is administered as an adjunct to diet and exercise to improve the glucose control of patients with type 2 diabetes.
    – Monotherapy
    – Combination therapy

  • Aprovasc®Tablet 150/10mg

    Aprovasc®Tablet 150/10mg

    Ingredient

    Amlodipine Besylate 14mg (Amlodipine 10mg)
    Irbesartan 150mg

    Content

    Pink oval film-coated tablet

    Indication

    Essential hypertension not adequately controlled with Irbesartan monotherapy

  • Aprovasc®Tablet 150/5mg

    Aprovasc®Tablet 150/5mg

    Ingredient

    Amlodipine Besylate 7mg (Amlodipine 5mg)
    Irbesartan 150mg

    Content

    White oval film-coated tablet

    Indication

    Essential hypertension not adequately controlled with Irbesartan monotherapy

  • Aprovasc®Tablet 300/5mg

    Aprovasc®Tablet 300/5mg

    Ingredient

    Amlodipine Besylate 7mg (Amlodipine 5mg)
    Irbesartan 300mg

    Content

    Yellow oval film-coated tablet

    Indication

    Essential hypertension not adequately controlled with Irbesartan monotherapy

TOP